Urology

Your Article Summary

See Latest Articles

The effect of intravesical oxybutynin on the ice water test and on electrical perception thresholds in patients with neurogenic detrusor overactivity
Neurourology and Urodynamics, 09/30/09

Van Meel TD et al. – Intravesical oxybutynin blocks the bladder–cooling reflex and increases but does not block CPT sensation in the bladder in most patients with incomplete neurogenic lesion and detrusor overactivity. These results help explain the clinical effect of intravesical oxybutynin in neurogenic patients. They also indicate that a pharmacological local influence on C–fiber–related activity can give different clinical effects.

Today in Bladder...keeping you current

Receive free subspecialty "5-minute updates" via email

Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09

Survivin as a prognostic marker for urothelial carcinoma of the bladder: A multicenter external validation study
Clinical Cancer Research, 11/17/09

Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: Results in 1005 patients
Annals of Oncology, 11/10/09

See All of Bladder

Today in Voiding Dys/Incontinence...keeping you current

Receive free subspecialty "5-minute updates" via email

Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09

TVT and TVT-O for surgical treatment of primary stress urinary incontinence: prospective randomized trial
International Urogynecology Journal, 11/17/09

Fesoterodine for the treatment of urinary incontinence and overactive bladder
Therapeutics and Clinical Risk Management, 11/04/09

See All of Voiding Dys/Incontinence